ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,916.45
-0.01%
US Tech 100
20,264.20
0.68%
다우존스 지수
43,451.12
0.10%
Bitcoin
97,365.03
3.18%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE
  6. Hemogenyx Pharmaceuticals Plc (HEMO)

  7. Hemogenyx Pharmaceuticals Plc (HEMO) 뉴스

HEMO

Hemogenyx Pharmaceuticals (HEMO)

Hemogenyx Pharmaceuticals Plc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:HEMO
일자시간출처헤드라인심볼기업
2024/11/1116:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Institutional InvestmentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/10/3020:09Alliance NewsAlliance NewsIN BRIEF: Hemogenyx to launch myeloid leukemia treatment phase 1 trialLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/10/3016:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Schedule for Phase I Clinical Trial OpeningLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/10/0219:19RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Strategic Investment from Prevail Partners, LLCLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/2802:25Alliance NewsAlliance NewsHemogenyx Pharmaceuticals loss narrows amid reduced expensesLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/2723:55Alliance NewsAlliance NewsEARNINGS: Clean Power Hydrogen loss widens; Invinity loss narrowsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/2715:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Half-year ReportLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/1006:03Alliance NewsAlliance NewsTRADING UPDATES: Light Science Technologies wins two new contractsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/0915:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC FLT3 Assay Ready for Phase I Trials at MD AndersonLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/09/0215:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CDX Development UpdateLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/08/2815:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Presentation at CBD S&T ConferenceLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/07/2915:00RNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Macrophage-Directed Therapies Summit PresentationLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/06/2800:39RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Result of Annual General MeetingLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/06/1803:55Alliance NewsAlliance NewsIN BRIEF: Hemogenyx Pharmaceuticals updates on leukemia treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/06/1715:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Operations UpdateLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/06/0315:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Posting of Annual Report & Notice of AGMLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/04/2520:19Alliance NewsAlliance NewsEARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payoutLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/04/2515:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Final ResultsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/03/2816:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/2923:04Alliance NewsAlliance NewsHemogenyx Pharmaceuticals raises money for leukaemia treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/2916:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Placing to Raise US$4.2 millionLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1620:27Alliance NewsAlliance NewsHemogenyx shares rise on potential for CBR to treat brain diseasesLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1616:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Brain DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1419:14Alliance NewsAlliance NewsHemogenyx says CBR can be used intranasally to treat viral infectionsLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/1416:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Intranasal DeliveryLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0919:00Alliance NewsAlliance NewsIN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial holdLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0916:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC FDA Consents to Phase I Trials of HEMO-CAR-TLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0219:44Alliance NewsAlliance NewsIN BRIEF: Hemogenyx hails US patent application progressLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/02/0216:00RNS Regulatory NewsHemogenyx Pharmaceuticals PLC Approval and Issuance of U.S. Conditioning PatentLSE:HEMOHemogenyx Pharmaceuticals Plc
2024/01/1620:13Alliance NewsAlliance NewsHemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDALSE:HEMOHemogenyx Pharmaceuticals Plc
 검색 관련기사 보기:LSE:HEMO

최근 히스토리

DOWI
DJDGREUT
DJ Developed Green Real ...
LSE
ATG
Auction Technology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유